Charting a path for our members.
Author(s): Fridsma, Douglas B
DOI: 10.1093/jamia/ocw170
Author(s): Fridsma, Douglas B
DOI: 10.1093/jamia/ocw170
Author(s): Ohno-Machado, Lucila
DOI: 10.1093/jamia/ocw163
Electronic health records (EHRs) are a resource for "big data" analytics, containing a variety of data elements. We investigate how different categories of information contribute to prediction of mortality over different time horizons among patients undergoing hemodialysis treatment.
Author(s): Goldstein, Benjamin A, Pencina, Michael J, Montez-Rath, Maria E, Winkelmayer, Wolfgang C
DOI: 10.1093/jamia/ocw057
Our objective was to develop an approach for selecting combinatorial markers of pathology from diverse clinical data types. We demonstrate this approach on the problem of pancreatic cyst classification.
Author(s): Masica, David L, Dal Molin, Marco, Wolfgang, Christopher L, Tomita, Tyler, Ostovaneh, Mohammad R, Blackford, Amanda, Moran, Robert A, Law, Joanna K, Barkley, Thomas, Goggins, Michael, Irene Canto, Marcia, Pittman, Meredith, Eshleman, James R, Ali, Syed Z, Fishman, Elliot K, Kamel, Ihab R, Raman, Siva P, Zaheer, Atif, Ahuja, Nita, Makary, Martin A, Weiss, Matthew J, Hirose, Kenzo, Cameron, John L, Rezaee, Neda, He, Jin, Joon Ahn, Young, Wu, Wenchuan, Wang, Yuxuan, Springer, Simeon, Diaz, Luis L, Papadopoulos, Nickolas, Hruban, Ralph H, Kinzler, Kenneth W, Vogelstein, Bert, Karchin, Rachel, Lennon, Anne Marie
DOI: 10.1093/jamia/ocw069
This paper outlines the implementation of a comprehensive clinical pharmacogenomics (PGx) service within a pediatric teaching hospital and the integration of clinical decision support in the electronic health record (EHR).
Author(s): Manzi, Shannon F, Fusaro, Vincent A, Chadwick, Laura, Brownstein, Catherine, Clinton, Catherine, Mandl, Kenneth D, Wolf, Wendy A, Hawkins, Jared B
DOI: 10.1093/jamia/ocw052
Medication reconciliation (MedRec) is essential for reducing patient harm caused by medication discrepancies across care transitions. Electronic support has been described as a promising approach to moving MedRec forward. We systematically reviewed the evidence about electronic tools that support MedRec, by (a) identifying tools; (b) summarizing their characteristics with regard to context, tool, implementation, and evaluation; and (c) summarizing key messages for successful development and implementation.
Author(s): Marien, Sophie, Krug, Bruno, Spinewine, Anne
DOI: 10.1093/jamia/ocw068
Inductive machine learning, and in particular extraction of association rules from data, has been successfully used in multiple application domains, such as market basket analysis, disease prognosis, fraud detection, and protein sequencing. The appeal of rule extraction techniques stems from their ability to handle intricate problems yet produce models based on rules that can be comprehended by humans, and are therefore more transparent. Human comprehension is a factor that may [...]
Author(s): Guillame-Bert, Mathieu, Dubrawski, Artur, Wang, Donghan, Hravnak, Marilyn, Clermont, Gilles, Pinsky, Michael R
DOI: 10.1093/jamia/ocw048
There are concerns that structured electronic documentation systems can limit expressivity and encourage long and unreadable notes. We assessed the impact of an electronic clinical documentation system on the quality of admission notes for patients admitted to a general medical unit.
Author(s): Jamieson, Trevor, Ailon, Jonathan, Chien, Vince, Mourad, Ophyr
DOI: 10.1093/jamia/ocw064
We created a system using a triad of change management, electronic surveillance, and algorithms to detect sepsis and deliver highly sensitive and specific decision support to the point of care using a mobile application. The investigators hypothesized that this system would result in a reduction in sepsis mortality.
Author(s): Manaktala, Sharad, Claypool, Stephen R
DOI: 10.1093/jamia/ocw056
Our objective is to test the limits of the assumption that better learning from data in medicine requires more granular data. We hypothesize that clinical trial metadata contains latent scientific, clinical, and regulatory expert knowledge that can be accessed to draw conclusions about the underlying biology of diseases. We seek to demonstrate that this latent information can be uncovered from the whole body of clinical trials.
Author(s): Haslam, Bryan, Perez-Breva, Luis
DOI: 10.1093/jamia/ocw003